http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006008686-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25e8addd8fc200645a64ef15934e6587 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
| filingDate | 2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd0e5438f757a1faf582216aa433939f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0dfa1faf7c8a3474fdb9984b14de719 |
| publicationDate | 2006-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006008686-A |
| titleOfInvention | Method for producing imiquimod |
| abstract | The present invention provides a novel process for producing imiquimod and novel hydroxylamino and hydrazine derivatives useful as intermediates in the production. The process comprises reacting 4-chloro-1-isobutyl-1H-imidazo [4,5-c] quinoline of formula (I) with an amine compound of formula (II), followed by reduction if necessary. React with agent. [Chemical 1] NH 2 -X (II) [In the formula (II), X represents an —OR group or —NR 1 R 2 group, and R represents hydrogen, a C 1 -C 6 alkyl group, an aryl-C 1 -C 4 alkyl group, an aryl group, or —SO 3. H (sulfone) group, R 1 and R 2 are each independently hydrogen, C 1 -C 6 alkyl group, aryl-C 1 -C 4 alkyl group, aryl group or —SO 2 R 3 group, R 3 is an aryl group. ] [Selection figure] None |
| priorityDate | 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.